• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Complement component C8 alpha chain (C8A)

ACP01793

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01793 Target NameC8A
Target SynonymsComplement component 8 subunit alphaFormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range31-584aa
Mol Weight65.8 kDaProtein LengthFull Length of Mature Protein
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP07357
Background Information
  • Uniprot Id

    P07357

  • Target Species

    Human

  • Target Name

    C8A

  • Target Full Name

    Complement component C8 alpha chain

  • Target Function

    Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C8A inserts into the target membrane, but does not form pores by itself.

  • Target Involvement

    Complement component 8 deficiency, 1 (C8D1)

  • Target Subcellular Location

    Secreted. Cell membrane; Multi-pass membrane protein. Note=Secreted as soluble protein. Inserts into the cell membrane of target cells.

  • Target Protein Families

    Complement C6/C7/C8/C9 family

  • Target Research Area

    Immunology

  • Target Synonyms

    C8A; CO8A_HUMAN; Complement component 8 subunit alpha; Complement component 8, alpha polypeptide; Complement component C8 alpha chain

Inquire Recombinant Human Complement component C8 alpha chain (C8A) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification